Pages that link to "Q71994952"

The following pages link to Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression (Q71994952):

Displaying 24 items.

• Theiler's virus infection: a model for multiple sclerosis (Q24629115) (← links)
• Antigen-based immunotherapy for autoimmune disease: current status (Q26852915) (← links)
• Oral tolerance: mechanisms and therapeutic applications. (Q33683196) (← links)
• Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity (Q34002486) (← links)
• Effect of a monoclonal antibody against interleukin‐4 on collagen‐induced arthritis in mice (Q35027098) (← links)
• Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific (Q35298191) (← links)
• Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes (Q35782480) (← links)
• Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin (Q36771712) (← links)
• Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. (Q38078552) (← links)
• Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis? (Q39706642) (← links)
• Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-a-treated lewis rats: Future treatment of endogenous posterior uveoretinitis? (Q40909960) (← links)
• Oral tolerance: mechanisms and possible role in inflammatory joint diseases (Q41010927) (← links)
• Expression and characterization of recombinant human type II collagens with low and high contents of hydroxylysine and its glycosylated forms (Q41058262) (← links)
• Oral tolerance: immune mechanisms and treatment of autoimmune diseases (Q41546336) (← links)
• Immunological Treatment of Autoimmune Diseases (Q41722148) (← links)
• Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis (Q41837521) (← links)
• Oral tolerance in disease (Q43040918) (← links)
• Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis. (Q44461538) (← links)
• Modulation by cytokines of induction of oral tolerance to type II collagen. (Q54107294) (← links)
• The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells. (Q55024614) (← links)
• Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope (Q71018489) (← links)
• Suppression of antigen‐induced arthritis in lewis rats by oral administration of type ii collagen (Q71970885) (← links)
• T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro (Q77419342) (← links)
• Oral tolerance and the treatment of rheumatoid arthritis (Q77627766) (← links)